Carlson T H, Atencio A C, Simon T L
J Clin Invest. 1984 Jul;74(1):191-9. doi: 10.1172/JCI111401.
Rabbit antithrombin III (AT), purified by heparin-agarose, was labeled with iodine-131 by either the glucose oxidase-lactoperoxidase or iodine monochloride techniques. When intravenously injected, the disappearance of the 131I-AT from plasma was characterized by rapid initial decreases, and three-exponential equations were required for best fit of the plasma disappearance curves. This rapid 131I-AT removal was not caused by denaturation, as shown by comparison with results obtained when 131I-AT was biologically screened (injected into a first rabbit, and then transferred 16 h later in whole plasma to a second for kinetic evaluation) before injection. Thus, the same rapid initial loss of plasma 131I-AT was observed with screened preparations, and the plasma fractional catabolic rates of 0.716 +/- 0.048 and 0.673 +/- 0.051 day-1 for unscreened and screened 131I-AT were not significantly different. These results support the hypothesis that a vascular-endothelial AT compartment is present in rabbit. The fractions of the total-body AT in the plasma, the vascular-endothelial and the extravascular compartments were 0.337 +/- 0.031, 0.178 +/- 0.056, and 0.485 +/- 0.069, respectively. Two three-compartment kinetic models are discussed. The first pictures AT as distributing independently between plasma and two other compartments, and the second sees AT as first passing to the vascular-endothelial compartment, and then directly into the extravascular compartment. The plasma 131I-AT kinetic data was consistent with both models, but the sizes of the vascular-endothelial compartments were best predicted by the second. If AT catabolism was assigned to the plasma, both models generally underpredicted the whole-body radioactivities, while assignment of breakdown to the extravascular compartment generally resulted in overpredictions. This suggests that AT catabolism occurs from both plasma and extravascular compartments.
通过肝素 - 琼脂糖纯化的兔抗凝血酶III(AT),采用葡萄糖氧化酶 - 乳过氧化物酶或一氯化碘技术用碘 - 131进行标记。静脉注射后,血浆中131I - AT的消失表现为最初迅速下降,血浆消失曲线的最佳拟合需要三指数方程。这种131I - AT的快速清除不是由变性引起的,这通过与注射前对131I - AT进行生物学筛选(注入第一只兔子,16小时后将全血浆转移至第二只兔子进行动力学评估)所获得的结果进行比较得以证明。因此,筛选后的制剂也观察到血浆131I - AT同样迅速的初始损失,未筛选和筛选后的131I - AT的血浆分数分解代谢率分别为0.716±0.048和0.673±0.051天-1,两者无显著差异。这些结果支持了兔体内存在血管内皮AT区室的假说。血浆、血管内皮和血管外区室中全身AT的分数分别为0.337±0.031、0.178±0.056和0.485±0.069。讨论了两种三室动力学模型。第一种模型将AT描绘为在血浆和其他两个区室之间独立分布,第二种模型认为AT首先进入血管内皮区室,然后直接进入血管外区室。血浆131I - AT动力学数据与两种模型均相符,但第二种模型对血管内皮区室大小的预测最佳。如果将AT分解代谢归因于血浆,两种模型通常都会低估全身放射性,而将分解归因于血管外区室通常会导致高估。这表明AT分解代谢发生在血浆和血管外区室。